ING

ING Groep
D

ING

Arincen39/100B

ING Groep stock forecast 2027–2029

Analysts' average 12-month price target for ING Groep is 22.50, 29.3% below the current price of 31.81. Their targets range from 22.50 to 22.50.

Of the 17 firms that rated ING Groep in the past 12 months, 11 rate it buy or strong buy, 6 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.

12-month price target
22.50 USD
-29.27%

Analysts' 1-year price targets range from 22.50 to 22.50, with an average of 22.50.

Past year
1-year forecast
Strong sellStrong buy
Buy
17 ratings
Buy
11
Hold
6
Sell
0

12-month price target

Highest target22.50
Average target22.50
Lowest target22.50
Current price31.81

ING Groep price target history

See how analysts moved their price target

How analysts rate ING Groep, month by month

1 of 1 firms rate it buy now, against 1 of 1 in December 2025.

Buy Hold Sell

Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.

Month endBuyHoldSellFirms
Jun 20261001
May 20261001
Apr 20261001
Mar 20261001
Feb 20261001
Jan 20261001
Dec 20251001

ING Groep EPS and revenue estimates

Analysts expect ING Groep's EPS to grow 18.5% a year until 2027, slower than over the last 5 years (27.1% a year) and the last 3 years (28.0%).

Analysts expect ING Groep's revenue to grow 7.3% a year until 2028. Over the last 5 years it fell 3.1% a year, and over the last 3 years it fell 11.8%.

Revenue

ReportedEstimate

EPS

ReportedEstimate
Fiscal yearEPSEPS growthEPS rangeRevenueRevenue growthRevenue rangeAnalysts
FY2027 (est.) 3.32+38.9%2.88 – 3.71 29.88B-38.4%29.30B – 30.45B3
FY2025 2.39+11.7%— 48.51B-47.2%——
FY2024 2.14-3.2%— 91.96B+276.8%——
FY2023 2.21+110.6%— 24.41B+24.2%——
FY2022 1.05—— 19.66B———

Does ING Groep beat earnings estimates?

On average, analysts' EPS estimate was 16.6% off the result, either way, and their revenue estimate 136.9%, over the last 12 quarters.

EPS beats
14 / 23
Revenue beats
13 / 20
Average EPS surprise, last 12
+12.5%
Since
November 2013
QuarterReport dateEPS estimateReported EPSSurpriseRevenue estimateReported revenueSurprise
Q3 FY202629 Oct 20260.790.75-5.1%7.06B6.95B-1.6%
Q2 FY202630 Jul 20260.750.79+5.3%6.99B7.23B+3.4%
Q1 FY202630 Apr 20260.600.63+5.0%6.86B6.83B-0.4%
Q4 FY202529 Jan 20260.500.56+12.0%6.67B6.92B+3.7%
Q3 FY202530 Oct 20250.640.70+9.4%6.28B6.86B+9.2%
Q2 FY202531 Jul 20250.590.64+8.5%6.22B28.56B+358.9%
Q1 FY20252 May 20250.560.49-12.5%6.34B6.18B-2.6%
Q4 FY20246 Feb 20250.410.39-4.9%5.77B5.60B-2.9%
Q3 FY202431 Oct 20240.300.65+114.2%6.13B54.51B+789.7%
Q2 FY20241 Aug 20240.540.58+7.6%5.99B29.96B+400.5%
Q1 FY20242 May 20240.460.52+12.3%5.83B1.89B-67.6%
Q4 FY20231 Feb 20240.490.48-2.0%6.07B5.95B-1.9%

ING Groep stock price 2027–2029: scenarios

If ING Groep's earnings grow at the 17.9% a year analysts expect to FY2027, then 15.0% a year, it would earn about 4.39 a share in FY2029. At the P/E it has traded at over the last five years (9.2 to 12.2) that is 40.27 to 53.55 a share, or 47.87 at its average P/E of 10.9. This is arithmetic on the analysts' estimates, not a prediction.

Bull Base Bear
Fiscal yearEPSBearBaseBull
FY2027 3.3230.4536.2040.49
FY2028 (extrapolated)3.8235.0241.6346.56
FY2029 (extrapolated)4.3940.2747.8753.55

Each year's EPS is the analysts' consensus to FY2027; the years after grow 15.0% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (9.2, 10.9, 12.2).

Is ING Groep stock undervalued or overvalued?

ING Groep's P/E of 12.2 is above the middle of its 5-year range (6.2 to 14.0, median 10.1). Analysts do not expect faster growth than in recent years, so it is expensive compared with its own history. Buyers pay more for each point of growth than usual: a PEG of 0.7 on expected growth against 0.4 on its median P/E and past five years' growth. At its usual P/E (10.2 × EPS of 2.61), ING Groep's fair value is 26.72; the price, 31.81, is ⁦19.0%⁩ above it. Its forward P/E, on the consensus for FY2026, is 11.4.

The price against its fair value
Fair value 26.72Price 31.8116.1536.62

Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (6.2 and 14.0). The price against its P/E range

Price to earnings ratio (TTM)
12.19
Five-year median P/E
10.08
Five-year P/E range
6.2 – 14.0
Forward P/E (FY2026)
11.37
PEG ratio
0.68
To the average target
-29.3%
See the full P/E history check Plus

Most undervalued US stocks

StockPriceFair valueUpside
99.090
194.93146Price 99.09244
+96.7%
42.225
82.9546Price 42.23165
+96.4%
186.680
360.82271Price 186.68451
+93.3%
213.670
405.57304Price 213.67507
+89.8%
161.160
305.51157Price 161.16396
+89.6%
160.650
300.09225Price 160.65375
+86.8%
165.860
308.95212Price 165.86442
+86.3%

Furthest below the fair value on each stock's page, updated every day.

Common questions about the ING Groep stock forecast

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.